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ABSTRACT
Many similarities exist between research on combinatorial chemis-
try and natural products and research on dietary supplements and
botanicals at the National Institutes of Health (NIH) Botanical Re-
search Centers. The technologies used at the centers are similar to
those used by other NIH-sponsored investigators. All centers rigor-
ously examine the authenticity of botanical dietary supplements and
determine the composition and concentrations of the phytochemi-
cals therein, most often by liquid chromatography–mass spectrom-
etry. Several of the centers specialize in fractionation and high-
throughput evaluation to identify the individual bioactive agent or a
combination of agents. Some centers are using DNA microarray
analyses to determine the effects of botanicals on gene transcription
with the goal of uncovering the important biochemical pathways
they regulate. Other centers focus on bioavailability and uptake,
distribution, metabolism, and excretion of the phytochemicals as for
all xenobiotics. Because phytochemicals are often complex mole-
cules, synthesis of isotopically labeled forms is carried out by plant
cells in culture, followed by careful fractionation. These labeled
phytochemicals allow the use of accelerator mass spectrometry to
trace the tissue distribution of 14C-labeled proanthocyanidins in
animal models of disease. State-of-the-art proteomics and mass
spectrometry are also used to identify proteins in selected tissues
whose expression and posttranslational modification are influenced
by botanicals and dietary supplements. In summary, the skills
needed to carry out botanical centers’ research are extensive and may
exceed those practiced by most NIH investigators. Am J Clin
Nutr 2008;87(suppl):476S–80S.
KEY WORDS Activity-guided fractionation, bioavailability,
isotopic labeling of phytochemicals in plant cell culture, DNA mi-
croarray analysis, 2D-gel electrophoresis, peptide mass fingerprint-
ing, tandem mass spectrometry
INTRODUCTION
Under the provisions of the Dietary Supplement Health and
Education Act, dietary supplements in use on or before 25 Oc-
tober 1994, may be sold in the United States (1). One provision
of the Act was the creation of the Office of Dietary Supplements
(ODS) at the National Institutes of Health (NIH) to promote
scientific study on dietary supplements. As part of this mandate,
the ODS supports several NIH Botanical Research Centers
whose purpose is to conduct state-of-the-science research on the
efficacy, safety, and mechanisms of action of botanicals and
other ingredients used in dietary supplements. Research on botani-
cal supplements in centers therefore represents a particularly com-
plex set of endeavors. The purpose of this presentation is to describe
some of the complexities involved in studying botanical ingredients
and to show how research in the botanicals centers is being carried
out and is setting new standards for all of NIH research.
FOODS, DIETARY SUPPLEMENTS, BOTANICALS, AND
DRUGS
The similarities and differences among foods, dietary supple-
ments, botanicals, and drugs must be distinguished. They are all
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xenobiotics. Foods are plants, animals, and other previously
living forms that are safe although they are not necessary nutri-
tious. Dietary supplements are food-derived and are also gener-
ally regarded as safe under conditions of use although they are not
necessarily nutritious. Botanicals and their extracts used as in-
gredients in dietary supplements are generally associated with
alleged improvements in health and risk of disease; they are
assumed to be safe although they may also have unanticipated
toxic effects when consumed as dietary supplements rather than
under conditions of use associated with traditional medicine ap-
plications. Unlike vitamins and minerals, botanical supplements
are rarely significant sources of nutrients. Drugs are designed to
be efficacious for specific health uses and safety is evaluated in
the context of risk-benefit relations. They are rarely significant
sources of nutrients.
THE COMPLEX NATURE OF DIETARY SUPPLEMENTS
AND BOTANICALS
Much of NIH-funded research is characterized by a need to
understand the molecular or mechanistic basis of disease and of
the agents that alleviate or treat the disease. To achieve these
goals, an emphasis is placed on reducing complex problems to
manageable sizes—a reductionist approach. A criticism often
cast at dietary supplement research is that a dietary supplement is
not a single compound nor is its composition tightly controlled.
However, its complex nature may be its strength (2). It may
contain multiple compounds with primary bioactivity as well as
adjunct bioactivity (ie, properties that enhance the delivery or
activity of the bioactive components). An example of this is
(-)-epigallocatechin-3-gallate (EGCG), the most bioactive com-
ponent of green tea. On its own, EGCG is unstable and readily
degraded before it is consumed, well before reaching its biolog-
ical target. It has greater biological activity in green tea than alone
because of the presence of other catechins (3). Investigators
outside of botanicals research are familiar with the need to pro-
vide carriers for bioactive agents.
FRACTIONATION, BIOACTIVITY, AND
BIOAVAILABILITY
In research being carried out at botanical centers, investigators
first perform experiments to identify the principal bioactive com-
ponents by fractionating extracts of the dietary supplement or
botanical and then testing the activity of each fraction in a suit-
able cell culture model or high-throughput assay system. This
approach is the same as carried out in drug companies and uni-
versity research laboratories that examine compounds generated
by combinatorial chemistry or from natural inedible products.
Once compounds with possible bioactivity have been identified
(whether from dietary supplements and botanicals or high-
throughput assays), they are subjected to standard absorption,
distribution, metabolism, and excretion experiments in small and
then larger animals. Investigators also carry out dose-range ex-
periments in the whole animal model and determine whether
toxicity occurs with acute or long-term exposure. What distin-
guishes botanical centers research from other NIH research is
that botanicals investigators then examine the activity of the
whole dietary supplement at doses that deliver the same amount
of the bioactive material as isolated from the supplement. This
enables the investigator to assess whether other components of
the dietary supplement or botanical matrix have synergistic ef-
fects.
TECHNOLOGIES IN THE BOTANICAL CENTERS
Activity-guided chemical fractionation
Fractionation of botanicals and dietary supplements is carried
out at the University of Illinois-Chicago (to isolate compounds
with estrogenic activity), Iowa State University (to isolate bio-
active compounds from Echinacea and Hypericum species), and
Pennington Biomedical Research Center-Rutgers University (to
isolate compounds that suppress the metabolic syndrome). Iden-
tification of the bioactive compounds requires the use of reverse-
and normal-phase HPLC, high-resolution mass spectrometry,
1H- and 13C-nuclear magnetic resonance spectrometry, and other
modern analytic methods.
High-throughput analysis
The high-throughput methods used to find the bioactivities of
phytochemicals in botanicals are identical to those used to ex-
amine synthetic drugs. For instance, at the University of Illinois-
Chicago botanicals center, phytoestrogen activity is examined by
using an in vitro receptor binding assay and cultured cell ap-
proach using a human breast tumor MCF-7 cell line with an
alkaline phosphatase or luciferase reporter gene (4). The same
center has used ultrafiltration mass spectrometry to assess the
binding of phytoestrogens to estrogen receptors (Figure 1; 5).
Composition and quality control
Determining the composition of the dietary supplement prep-
arations is vital to botanical centers research. To ensure that
research studies use dietary supplements that reflect those avail-
able to the public, the National Center for Complementary and
FIGURE 1. Ultrafiltration mass spectrometry (MS) screening of plant
phytochemicals for their roles as ligands for estrogen receptor- (ER) and
ER. This is a total ion chromatogram after liquid chromatography–negative
ion electrospray ionization MS of ultrafiltrates obtained from incubations of
ER and ER with an extract of hops. The control chromatogram was
obtained by using denatured ER. Compound XN, although giving strong
signals, was bound to ER and nonspecifically to ER. In contrast, com-
pound IX and 8-prenylnaringin (8-PN) were high-affinity ligands. Int. std.,
internal standard. Reprinted with permission from Overk et al (4). Copyright
2005 American Chemical Society.














Alternative Medicine set up a working group to review the ap-
plications it receives (6). Applications that have inadequate an-
alytic methods, do not have a product with known composition,
or do not have plans to assess degradation are not approved for
funding until these limitations are addressed.
Several of the botanical centers are engaged in clinical trials
of botanical agents from the United States and other countries
with different medical cultures. The Memorial-Sloan-Kettering
Cancer Center specializes in materials used in Chinese tradi-
tional medicine. In such cases, much use is made of liquid
chromatography–mass spectrometry (LC-MS) to validate the
composition of the dietary supplements as well as the concen-
trations of the bioactive compounds in blood, urine, and other
biological fluids and tissues.
ABSORPTION, DISTRIBUTION, METABOLISM, AND
EXCRETION
Most methods used to study the bioavailability, pharmacoki-
netics, and metabolism of specific compounds in dietary supple-
ments and botanicals are based on the qualitative and quantitative
use of LC-MS. These studies have been carried out in humans, in
small and large animals, and in in vitro models. Richard van
Breemen’s group at the University of Illinois-Chicago used
Caco-2 cells combined with LC-MS to estimate the rate of in-
testinal uptake and metabolism of specific plant phytochemicals
(Figure 2; 7, 8). Chao-Chen Wang at the University of Alabama
at Birmingham (UAB) applied a microsampling technique with
LC-MS to determine the concentrations of genistein and its 7-O-
-D-glucuronide in the aqueous humor of rats fed genistein in the
diet (Figure 3; 9). Elsa Janle at Purdue University applied an
automated collection system to obtain blood samples from non-
anesthetized, free-moving rats (10).
USE OF ACCELERATOR MASS SPECTROMETRY
The eclectic nature of the botanical centers in some cases
allows for unusual combinations of methods. Investigators at the
Purdue-UAB botanicals center are applying accelerator mass
spectrometry to follow 2 rare radioactive isotopes (14C and 41Ca)
in biological experiments. The extreme sensitivity of accelerator
mass spectrometry allows for the detection of one 14C or 41Ca
atom in 1015 atoms of nonradioactive carbon or calcium. Connie
Weaver at Purdue University administered a single dose of 41Ca
to postmenopausal women to examine the effects of phytoestro-
gen dietary supplements on the turnover of calcium in bone; this
study has been going on for 5 y in the same subjects (11). Mary
Ann Lila, at the University of Illinois-Urbana-Champaign, man-
ufactures 14C-labeled complex phytochemicals such as proan-
thocyanidins with plant cell culture systems (12). Although these
can be used in conventional radiotracer experiments to assess
uptake and metabolism, the extreme sensitivity of AMS allows
for careful tissue-by-tissue analysis of proanthocyanidin metab-
olism using only very small doses (50 nCi).
PROTEOMICS AND PROTEIN MASS SPECTROMETRY
The combination of dietary supplements and botanicals re-
search with modern proteomics and protein MS for several years
seemed to many an oxymoron. However, if dietary supplements
are to have biological action, they will affect protein abundance
and activity. Helen Kim and colleagues at UAB fed rats a diet
containing grape seed extract for 6 wk and identified 14 brain
proteins that were changed by grape seed extract (13). They
applied a combination of 2D-isoelectric focusing and SDS-
PAGE resolution of the brain proteins, image analysis of stained
gels, peptide mass fingerprinting using matrix-assisted laser de-
sorption ionization-time of flight mass spectrometry (MALDI-
TOF MS), and peptide sequencing by LC-tandem MS (Figure
4). These studies identified creatine kinase as a candidate brain
protein undergoing changes in posttranslational modifications
that were induced by grape seed extract.
PROFILING AND IMAGING TECHNOLOGIES
Tissue profiling and imaging are other MS applications being
carried out in botanical centers. Stephen Barnes at UAB is ex-
amining the spatial changes in protein expression and modifica-
tion in the lens as part of a project on the role of phytochemicals
in the formation of cataracts. The lens proteins are unique in that
they are synthesized once and remain in the lens from womb to
tomb. Compounds that alter the rate of light-induced singlet
oxygen production in the lens may protect or enhance oxidation
FIGURE 2. Use of Caco-2 cells to monitor the bidirectional intestinal
transport of phytochemicals. The cells are first allowed to form a monolayer
and tight junctions between the cells. This enables phytochemicals to be
introduced on the luminal (A) or the serosal (B) side within the apparatus. The
fluid from the opposite side to which the phytochemical is applied is analyzed
by liquid chromatography–mass spectrometry to identify and quantify the
phytochemical and its metabolites. HBSS, Hank’s balanced salt solution.
Reprinted with permission from Li et al (8).
FIGURE 3. Isoflavones in the aqueous humor of the eye. Rats were fed
either an isoflavone-free AIN-76A diet or one supplemented with 400 mg/kg
genistein. The aqueous humor was removed from the eye under ketamine-
xylazine anesthesia and was analyzed by electrospray ionization mass spec-
trometry with a microfluidics approach. Parent ion-daughter ion transitions
were used to detect genistein (m/z 269/133) and its 7-O--glucuronide
(genistein GlcA; m/z 445/269). The full-scale intensities are given in the
upper right corner of the ion chromatograms. Rel. Int., relative intensity.
Reprinted with permission from Barnes et al with permission from Elsevier
(9).














and oligomerization of the lens proteins and hence cause the loss
of their chaperone function that maintains protein solubility.
These experiments are being carried out by using MALDI-TOF
MS (Figure 5) and high-resolution Fourier transform-ion cyclo-
tron resonance MS (Figure 6).
DNA ANALYSIS
Botanicals and dietary supplements may affect gene expres-
sion. DNA microarray analyses are being carried out by Ski
Chilton’s group at Wake Forest University to examine the effects
of n3 fatty acids in fish oil supplements to determine the bio-
chemical pathways that undergo changes in regulation. As for
many other areas of NIH clinical research, the effects of single
nucleotide polymorphisms may segregate subjects consuming
dietary supplements and botanicals into responders and nonre-
sponders. Similarly, supplements may have their effects epige-
netically by altering gene methylation (14) and by modulating
acetylation-deacetylation (15, 16) and potentially lysine
methylation-demethylation of histones.
SUMMARY
Research in the botanical centers demands the application of
the best technologies in current use. The demands brought by the
complex nature of the dietary supplements and botanicals are
setting new standards that will have impact throughout NIH-
funded research.
We thank David Stella for providing the unpublished data in Figure 5 and
Kerri Barrett, Shannon Eliuk, and Matthew Renfrow for the unpublished data
in Figure 6.
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FIGURE 4. 2D-proteomics mass spectrometry for protein discovery.
Young female rats were placed on an AIN-76A diet (controls) or an AIN-76A
diet supplemented with 5% grape seed extract for 6 wk. Whole brains were
harvested and homogenized. After solubilization in 7 mol/L urea–2 mol/L
thiourea, clarified extracts were subjected to 2D isoelectric focusing (pH
4–7) sodium dodecyl sulfate–polyacrylamide 10–20% gradient gel electro-
phoresis. The gels were fixed and then stained with colloidal Coomassie blue.
Protein spots were visualized by densitometry. Protein differences (spots
A–N) were determined by using BioRad (Hercules, CA) PDQuest imaging
software. Individual spots were cut out of the gel and subjected to trypsin
digestion. The resulting tryptic peptides from spots D and E were analyzed by
peptide mass fingerprinting (not shown) and by tandem MS. Manual inter-
pretation of the tandem MS spectrum confirmed that the protein was one for
which there was a matching record in a genomic database. Adapted with per-
mission from Deshane et al (13) Copyright 2004 American Chemical Society.
FIGURE 5. Matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF) profiling of proteins from the nuclear region of the lens of an
ICR/f rat. A portion of the nuclear region of the lens without visible cataracts
was homogenized in 10 L of 10 mmol/L tris buffer and centrifuged to yield
a soluble protein fraction. The solution (1 L) was mixed with 9 L of
saturated sinapinic acid in 50% aqueous acetonitrile. A 1-L aliquot was
spotted onto a MALDI target plate and allowed to dry. The plate was intro-
duced into the MALDI-TOF MS. Protein ions were generated by use of a
pulsed N2 laser operating at 337 nm and 2–3 Hz. Calibration of the protein
molecular weights was carried out by using a carbonic anhydrase standard.
FIGURE 6. Tandem mass spectrum of an oxidized tryptic peptide derived
from recombinantly expressed human B-crystallin. A desalted tryptic di-
gest (1 L) was resolved by nanoLC (Eksigent, Dublin, CA) on a 15 cm 
75 m internal diameter reversed-phase C18 column with a linear gradient of
5–95% acetonitrile in 0.1% formic acid at a flow rate of 200 nL/min. Fourier-
transform ion cyclotron resonance mass spectrometry (FT-ICR MS) analysis
was performed on a linear quadrupole ion trap (LTQ) FT-ICR hybrid mass
spectrometer (Thermo Electron, San Jose, CA). Eluted peptides were elec-
trosprayed at 2 kV. Peptide fragmentation was induced by collision-induced
dissociation in the ion trap and fragment ions were analyzed in the ICR cell.
The LTQ FT mass spectrometer was operated in a “top 3” data-dependent
acquisition mode. The mass spectrometer was set to switch between an
FT-ICR MS full scan (200–2000 m/z) followed by successive FT-ICR MS
single-ion monitoring scans and LTQ tandem MS scans of the 3 most abun-
dant precursor ions in the FT-ICR MS full scan as determined by the Xcalibur
software (Thermo Electron).
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